Perceptive Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-182,453
| Closed | -$4.6M | – | 231 |
|
2016
Q3 | $4.6M | Sell |
182,453
-4,067
| -2% | -$102K | 0.3% | 70 |
|
2016
Q2 | $4.61M | Hold |
186,520
| – | – | 0.32% | 57 |
|
2016
Q1 | $5.4M | Buy |
186,520
+62,500
| +50% | +$1.81M | 0.47% | 50 |
|
2015
Q4 | $4.6M | Hold |
124,020
| – | – | 0.34% | 52 |
|
2015
Q3 | $5.21M | Sell |
124,020
-26,250
| -17% | -$1.1M | 0.42% | 48 |
|
2015
Q2 | $10.4M | Sell |
150,270
-50,125
| -25% | -$3.46M | 0.62% | 35 |
|
2015
Q1 | $7.17M | Buy |
200,395
+137,500
| +219% | +$4.92M | 0.56% | 38 |
|
2014
Q4 | $795K | Buy |
62,895
+3,088
| +5% | +$39K | 0.07% | 96 |
|
2014
Q3 | $919K | Hold |
59,807
| – | – | 0.09% | 77 |
|
2014
Q2 | $1.62M | Hold |
59,807
| – | – | 0.16% | 66 |
|
2014
Q1 | $1.6M | Buy |
59,807
+5,875
| +11% | +$157K | 0.17% | 72 |
|
2013
Q4 | $1.33M | Hold |
53,932
| – | – | 0.16% | 57 |
|
2013
Q3 | $1.73M | Hold |
53,932
| – | – | 0.14% | 53 |
|
2013
Q2 | $1.6M | Buy |
+53,932
| New | +$1.6M | 0.16% | 43 |
|